“SCL is the only stem cell bank in Thailand”

that is authorized to legally cultivate and store stem cells by the Food and Drug Administration, the Ministry of Public Health. It is also the only company operating under a pharmaceutical manufacturing facility that has received international GMP (Good Manufacturing Practice) certification.

Certified by


Stem Cell for Life Co., Ltd was established with a focus on developing processes for isolation, cultivation, and storage of stem cells in accordance with international standards for stem cell storage. These standards include :

1. AABB (American Association of Blood Banks)
The standard established by the American Association of Blood Banks for the control of both donors and recipients in the field of therapeutic and cord blood stem cells, such as cord blood-derived hematopoietic stem cells.

2. ISCT (International Society for Cellular Therapy)
An international standard for cellular therapy that sets requirements for the isolation and critical evaluation of mesenchymal stem cells (MSCs), particularly those intended for future therapeutic use.

3. ISBT 128 (The Global Information Standard for Medical Products of Human Origin)
An international standard that pertains to the categorization of products intended for future therapeutic use, such as tissue transplantation, cellular therapy, and blood transfusion. This standard ensures global uniformity.


The Stem Cell for Life Co., Ltd Laboratory was established in a facility that adheres to GMP (Good Manufacturing Practice) standards, with a class 100 clean room, and is internationally certified. Additionally, it complies with the regulations set by the Food and Drug Administration (FDA) covering biological materials that will support the use of stem cells in the future.


The Stem Cell for Life Co., Ltd laboratory received ISO 9001:2015 certification, making it the only company in Thailand certified for the “MANUFACTURING OF STEM CELL” category under ISO 9001:2015. This means that every step of the process, from raw material selection and quality assurance of cell culture media, to controlled storage, precise quality control, pathogen and safety assurance, follows the GMP guidelines of pharmaceutical manufacturing.


Apply for License and Registration

Stem cell collection
from umbilical cord blood

It is easy to collect, takes less than 5 minutes, and causes no pain or harm to the baby or mother. It can be immediately used for babies who are the owners, without the need for tissue compatibility testing (HLA typing), and there is a high possibility of using it for family members or blood-related individuals.

Stem cell collection
from placental membrane

The umbilical cord tissue is a rich source of Mesenchymal stem cells (MSCs), which are highly beneficial for repairing various organs in the body, such as bone cells, cartilage cells, and muscle cells. The collection process does not pose any risk to the baby and the mother.

stem cell collection
from umbilical cord blood

The placental membrane is another source of MSCs. We are the first and only facility capable of cultivating and nurturing placental membrane, which possesses exceptional potential enhanced by these specific stem cells. For instance, it has a role in aiding the recovery from brain and nervous system-related conditions.

Stem Cell Collection
from Adipose Tissue

Adipose tissue is a source of MSCs that has been extensively studied for its potential in treating various diseases, such as ischemic heart muscle, diabetes, hypertension, inflammation, and even anti-aging. Furthermore, these MSCs are extracted from the individual’s own body (Autologous), making them a naturally compatible option. As a result, their usage is safer compared to introducing other foreign substances into the body.

Enhancement Service

Cultivating NK cells and increasing their quantity to an adequate level is challenging due to their low prevalence in the bloodstream and the high associated costs. However, SCL has developed a method to augment the quantity of NK cells and NK-T cells outside the body more effectively than conventional methods. This ultimately leads to Highly Active NK Cell Therapy – NK Cells, which can be utilized for ongoing applications.

HOTLINE 085-227-7909

A laboratory dedicated to the standard and safe cultivation of stem cells requires comprehensive control. This entails managing temperature, pressure, airflow, and air particle control. To achieve this, an efficient HEPA filter is incorporated to prevent small particles from entering the laboratory. The laboratory rooms are ordered according to particle levels found in the air, measured in particles/m3 of air. The SCL laboratory is categorized as a clean room class 100 (ISO 5), allowing no more than 100 particles/m3 of air exceeding 0.5 microns in size. Thus, maintaining a controlled clean room environment is essential for successful stem cell cultivation, ensuring the production of high-quality and safe cell products. The use of a clean room class 100 contributes to establishing a comparable standard for stem cell production to international benchmarks.

The process of storage, separation, and extraction of stem cells from blood is carried out in the SCL laboratory using a semi-automatic process. This approach enables multi-point risk management, allowing prompt adjustments when risks arise. By comparing it to labor-cost reduction methods involving the use of automated machinery, this semi-automatic approach allows for last-step adjustments, which can potentially impact the quality of cells extracted before storage.

The process of producing Mesenchymal stem cells at SCL laboratory has been requested for manufacturing authorization as per the aforementioned requirements. SCL is the sole company in Thailand to have received proper authorization. Additionally, SCL has been ISO 9001:2015 certified for stem cell manufacturing. It adheres to global standards for cell type identification and cell coding (ISBT 128 standards). SCL practices Good Manufacturing Practice (GMP) principles, including compliance with PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME (PIC/S) guidelines. Documentation controls ensure accurate and precise product outcomes in line with international standards (Standard Operating Procedure: SOP). Cell characteristics are checked according to ISCT (International Society for Cellular Therapy) criteria, ensuring that the stem cells processed through SCL’s stem cell production process are legally sound, of high quality, and utmost safety.